A new study published in the British Medical Journal (BMJ) has identified a link between the contraceptive injection Depo-Provera, manufactured by Pfizer, and an increased risk of meningiomas ...

“Pfizer claims to be a global leader in scientific innovation, yet in the case of Depo-Provera, it completely ignored credible scientific studies that connected the contraceptive to serious ...

The 33-year-old is one of many women globally questioning whether their use of a popular contraceptive called Depo-Provera contributed to the development of their brain tumour. Depo-Provera ...

Research in the British Medical Journal links the contraceptive injection Depo-Provera, by Pfizer, to an increased risk of brain tumors, especially with extended use. This has prompted potential ...

Depo-Provera was approved for contraceptive use in the United States in 1992, but studies going back to 1983 suggested that levels of synthetic progestin hormones found in Depo-Provera can bind to ...

Progestin-only oral contraceptives prescribed or dispensed ... levonorgestrel implant, Depo-Provera injection) are not usually recommended before 6 weeks postpartum unless other more appropriate ...

In March, the British Medical Journal published a study finding women who used contraceptives like Depo-Provera for more than a year had a five-to-six-fold increased chance of developing a type of ...